Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotime-Nasdaq's best kept secret? -- Ignore unavailable to you. Want to Upgrade?

To: Jumper who wrote (871)	4/29/1998 4:29:00 PM
From: Jim Roof	Respond to of 1432

Give me one instance of fraud for which the company should be held libel. I have no problem with management. Management has simply done what they said they were going to do. They have made good on their end of the deal and any stock performance that is contrary to one's personal pocketbook should be considered the price of trading stocks. It is risky. Always has been and always will be. While both Asensio and Biotime have clearly marked interests in the outcome of the stock trading (via insider shares - still being held by all) I would trust the empirical data presented by the company long long before the slamming by Asensio that has nothing but profit at its foundation. I see no explanation of the problems of Hextend by Asensio. I doubt he knows as much about it as I do. His firm may be on the money with some of their 'revelations' (Diana Corp. and Solvex come to mind) but I think he is basically taking advantage of a small stock with a small float in a volatile situation. They have cash. They just do not want to waste it on lawyers who probably have no legal ground for action anyway. It is frustrating to watch the blood-letting when I would want to make a forceful reply but that's just the way it is. I am still ahead on my investment. Jim